Zessly

Zessly (Infliximab) is a biosimilar medication used to treat inflammatory conditions like rheumatoid arthritis and Crohn’s disease. It works by targeting specific proteins in the immune system. This intravenous therapy supports symptom relief and disease management. A trusted option for autoimmune support in adults and children.

Infliximab, the active ingredient in Zessly, is prescribed to reduce inflammation and manage symptoms in autoimmune disorders such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is also used for moderate to severe Crohn’s disease and plaque psoriasis when other treatments are ineffective. Patients often ask, 'What is Infliximab used for?' to understand its role in long-term disease control and symptom improvement.

Many patients experience reduced joint pain and swelling after starting Infliximab therapy, which may improve mobility and daily functioning. Some notice a gradual decrease in skin plaques or gastrointestinal symptoms over time. Effects vary by individual and condition, so consistent monitoring with a healthcare provider is recommended.

Infliximab should be administered under medical supervision due to the risk of infusion reactions. Patients with active infections or a history of tuberculosis should discuss risks with their doctor before starting treatment. Regular health checks help ensure safe and effective use of this medication.

Infliximab may interact with other immunosuppressants or live vaccines, potentially increasing infection risk. Combining it with certain biologics or corticosteroids requires careful evaluation by a healthcare professional. Alcohol use and other medications should be reviewed to avoid adverse effects during therapy.